Goldhirsh Foundation Brain Tumor Research Awards Program

The Goldhirsh Foundation was established by Bernard A. Goldhirsh in 2000, shortly after he was diagnosed with brain cancer. He envisioned a grants program that would fund high-risk innovative brain tumor research. Prior to his death in 2003, he directed the Scientific Advisory Committee to identify those rare scientists who have brilliant ideas as well as a risk-taking style. Mr. Goldhirsh’s own career exemplified this entrepreneurial spirit. He launched two multi-million dollar magazines – Sail and Inc., the latter becoming one of the most successful magazines in history.

The Goldhirsh Foundation Brain Tumor Research Awards Program has awarded $17.3 million to 63 outstanding investigators working in U.S. and Israeli research institutions. Award recipients are developing novel drug delivery systems, creating new imaging techniques and investigating mechanisms by which glioblastoma tumors invade normal tissue. Other investigators are examining the basic biology of brain tumors while three Award recipients have launched clinical trials to assess the efficacy of new treatments. Collectively, the Goldhirsh Award recipients have advanced medical discoveries in brain tumor research.

The 2010 Grant Cycle is the final funding cycle for this Program. The Foundation wishes to acknowledge the generosity of time and the superb quality of reviews by the many distinguished investigators who served on the Scientific Advisory Committee these past nine years.